Edition:
United States

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

0.55USD
20 Apr 2018
Change (% chg)

$0.01 (+2.59%)
Prev Close
$0.54
Open
$0.56
Day's High
$0.59
Day's Low
$0.55
Volume
26,516
Avg. Vol
123,458
52-wk High
$2.75
52-wk Low
$0.45

Chart for

About

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $7.76
Shares Outstanding(Mil.): 13.91
Dividend: --
Yield (%): --

Financials

  ABIO.OQ Industry Sector
P/E (TTM): -- 31.01 33.60
EPS (TTM): -1.81 -- --
ROI: -113.69 13.60 13.19
ROE: -113.89 15.26 15.00

BRIEF-ARCA Biopharma Anticipates Meeting With FDA In Q2

* ARCA BIOPHARMA REPORTS TOPLINE PHASE 2B RESULTS FOR GENETIC-AF CLINICAL TRIAL

Feb 26 2018

BRIEF-Arca Biopharma announces issuance of European patent on cardiovascular disease treatment methods

* Arca Biopharma announces issuance of European patent for treating cardiovascular diseases and conditions with a new chemical entity utilizing genetic targeting

Nov 16 2017

BRIEF-ARCA Biopharma announces third quarter financial results

* ARCA Biopharma announces third quarter 2017 financial results and provides business update

Nov 09 2017

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $36.63 +0.10
Novartis AG (NOVN.S) CHF76.08 -1.20
Merck & Co., Inc. (MRK.N) $58.83 +0.19
Roche Holding Ltd. (ROG.S) CHF215.65 -0.85
Roche Holding Ltd. (RO.S) CHF220.00 -0.20
Abbott Laboratories (ABT.N) $59.19 -0.69
Bayer AG (BAYGn.DE) €99.00 -0.60
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €65.28 -0.32
Eli Lilly And Co (LLY.N) $79.06 -0.69

Earnings vs. Estimates